Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Nuojie Pharmaceutical is a comprehensive pharmaceutical enterprise based in Harbin, China, specializing in the research, development, and manufacturing of a diverse range of medicinal products. The company's portfolio includes both modern chemical pharmaceuticals and traditional Chinese medicines (TCM), addressing therapeutic areas such as respiratory health, cardiovascular disease, and infectious diseases. Nuojie Pharmaceutical operates multiple GMP-certified production lines for various dosage forms, including tablets, capsules, and granules. It is recognized as a key regional player in the Chinese healthcare market, providing essential medications like Pudilan Xiaoyan tablets and various antibiotic formulations. The company is committed to high-quality manufacturing standards and serves as a significant contributor to the pharmaceutical industry in Northeast China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 黑龙江诺捷制药.